| EPA023 | Immunotherapeutic blockades targeting LAG-3 and PD-1 immune checkpoint inhibitors on invariant Natural Killer T cells: implications in chronic HIV infection | E-poster | Innate immunity (including NK cells) |
| EPA024 | The effects of in utero HIV and anti-retroviral therapy exposure on infant T-cell and monocyte activation, function and regulation of immune-modulatory pathways | E-poster | Innate immunity (including NK cells) |
| EPA025 | HLA-B*46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypes | E-poster | Innate immunity (including NK cells) |
| EPA026 | Characterizing the effect of intracellular storage pools of RANTES/CCL5 on HIV infection in macrophages | E-poster | Innate immunity (including NK cells) |
| EPA027 | HIV-1 Vpu limits Fc-mediated effector functions in vivo | E-poster | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
| EPA028 | Metabolic gene profiling of activated, terminally differentiated effector memory and exhausted CD8+ T cells in people living with HIV | E-poster | Cellular immunity; T cell vaccines |
| EPA029 | BNT162b2 vaccine elicits impaired B cell and CD8 T cell responses combined with skewed CD4 T responses in patients receiving hemodialysis | E-poster | Cellular immunity; T cell vaccines |
| EPA030 | HIV-1-specific T-cells in an HIV-1-infected but HIV-1 antibody negative patient on long-term antiretroviral therapy | E-poster | Cellular immunity; T cell vaccines |
| EPA031 | Pomalidomide drives expansion of HIV-specific CD8+ T cells and enhances NK cell cytotoxicity to augment anti-HIV immunity | E-poster | Cellular immunity; T cell vaccines |
| EPA032 | Virtual memory CD8+ T-cells exhibit highly cytotoxic profiles in people with HIV, and are expanded by N-803 | E-poster | Cellular immunity; T cell vaccines |